Infinity Pharmaceuticals Inc. (INFI) Jumps 5.68% on February 17

Equities Staff |

Infinity Pharmaceuticals Inc. (INFI) was among the biggest gainers on the Russell 2000 for Wednesday February 17 as the stock popped 5.68% to $6.33, representing a gain of $0.34 per share. Some 482,086 shares traded hands on 3,690 trades, compared with an average daily volume of 924,600 shares out of a total float of 49.23 million. The stock opened at $6.06 and traded with an intraday range of $6.83 to $6.06.

After today's gains, Infinity Pharmaceuticals Inc. reached a market cap of $311.63 million. Infinity Pharmaceuticals Inc. has had a trading range between $16.98 and $5.24 over the last year, and it had a 50-day SMA of $6.84 and a 200-day SMA of $9.18.

Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is duvelisib, also known as IPI-145, an oral inhibitor.

Infinity Pharmaceuticals Inc. is based out of Cambridge, MA and has some 195 employees. Its CEO is Adelene Q. Perkins.

For a complete fundamental analysis analysis of Infinity Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for INFI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

International Western Petroleum Inc

International Western Petroleum Inc is an exploration-stage oil and natural gas company. The Company is engaged in the acquisition, development, and exploration of crude oil and natural gas properties in…

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…